摘要
目的探讨静脉丙种球蛋白在新生儿感染性疾病中的临床应用效果。方法选取本院2016年1月—2018年1月收治的重症肺炎新生患儿76例,随机分为治疗组与对照组,每组均为38例,对照组采取抗生素等其他常规药物进行治疗,治疗组在对照组的基础上加用丙种球蛋白进行治疗,比较两组在治疗后的效果。结果治疗组的治疗总有效率为92.10%,对照组的总有效率为68.42%,治疗组的总有效率优于对照组的总有效率,组间比较差异具有统计学意义(P<0.05)。结论对于新生儿感染性疾病应用丙球蛋白可以提高新生儿的免疫力。
Objective To investigate the clinical effect of intravenous gamma globulin in neonatal infectious diseases. Methods From January 2016 to January 2018, 76 newborns with infectious diseases were randomly divided into treatment group（n =38） and control group（n =38）. The control group was treated with antibiotics and other conventional drugs. The treatment group was treated with gamma globulin on the basis of the control group. Results The total effective rate of the treatment group was 92.10% and the total effective rate of the control group was 68.42%. The total effective rate of the treatment group was better than that of the control group, and the difference between the two groups was significant（P〈0.05）. Conclusion The application of immunological to neonatal infectious diseases can improve the immunity of newborns.
作者
汤利
TANG Li(Paediatrics Department, Shuyang Benevolent Hospital, Suqian Jiangsu 223600, China)
出处
《中国卫生标准管理》
2018年第18期74-76,共3页
China Health Standard Management
关键词
静脉丙种球蛋白
新生儿
感染性疾病
临床应用
有效率
效果
intravenous gamma globulin
newborns
infectious diseases
clinical application
efficiency
effect
